Back
Canopy Growth 10K Form
Sell
17
CGC
Canopy Growth
Last Price:
$1.12
Seasonality Move:
10.15%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-10 | 10Q | CGC/Canopy Growth Quarterly |
| 2020-07-29 | 10K | CGC/Canopy Growth Annual |
| 2020-06-01 | 10K | CGC/Canopy Growth Annual |
Receive CGC News And Ratings
See the #1 stock for the next 7 days that we like better than CGC
CGC Financial Statistics
Sales & Book Value
| Annual Sales: | $193.2M |
|---|---|
| Cash Flow: | $-26.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.85 |
| Price / Book: | 0.6 |
Profitability
| EPS (TTM): | -4.03870 |
|---|---|
| Net Income (TTM): | $-427.3M |
| Gross Margin: | $57.1M |
| Return on Equity: | -113.08% |
| Return on Assets: | -50.08% |
Canopy Growth Earnings Forecast
Key Canopy Growth Financial Ratios
-
The Gross Profit Margin over the past 16 years for CGC is 29.56%.
-
The Selling, General & Administrative Expenses for CGC have been equal to 45.25% of Gross Profit Margin.
-
The Research & Development expenses have been 1.55% of Revenue.
-
The Net Earning history of CGC is -222.35% of Total Revenues.
-
Per Share Earnings over the last 16 years have been positive in 8 years.
Canopy Growth Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CGC |
| CUSIP: | 138035 |
| Website: | canopygrowth.com |
Debt
| Debt-to-Equity Ratio: | 0.62 |
|---|---|
| Current Ratio: | 3.12 |
| Quick Ratio: | 1.95 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CGC Technical Analysis vs Fundamental Analysis
Sell
17
Canopy Growth (CGC)
is a Sell
Is Canopy Growth a Buy or a Sell?
-
Canopy Growth stock is rated a SellThe current Canopy Growth [CGC] share price is $1.10. The Score for CGC is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.